Usefulness of experimental models to understand the vascular effects of estrogens

被引:4
作者
Arnal, JF
Gourdy, P
Garmy-Susini, B
Delmas, É
机构
[1] INSERM, U589, F-31059 Toulouse, France
[2] CHU Rangueil, F-31059 Toulouse, France
来源
M S-MEDECINE SCIENCES | 2003年 / 19卷 / 12期
关键词
D O I
10.1051/medsci/200319121226
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Usefulness of experimental models to understand the vascular effects of estrogens. Hormonal replacement therapy does not prevent cardiovacular events in postmenopausal women. In contrast, the incidence of cardiovascular diseases is higher in men than in premenopausal women but increases in postmenopausal women, and all animal studies demonstrate a prevention of fatty streak deposit by estradiol. Although estradiol improves the lipoprotein profile, this effect can account for only a minor part of the protective effect. Endothelium appears to be an important target for estradiol, because this hormone potentiates endothelial nitric oxide (NO) production, thus promoting the beneficial effects of NO, such as vasorelaxation and inhibition of platelet aggregation. Estradiol accelerates endothelial regrowth, thus favoring vascular healing, and prevents apoptosis of endothelial cells. Estradiol prevents fatty streak deposit through a mechanism which is clearly independent of NO. The immunoinflammatory system appears to ploy a key role in the development of fatty streak deposit as well as in atherosclerotic plaque rupture. Mice deficient either in monocyte-macrophages or in lymphocytes are partially protected against fatty streak deposit. Interestingly, the atheroprotective effect of estradiol is absent in mice deficient in T and B lymphocytes. Most of these effects of estradiol are mediated by estrogen receptor alpha, and are independent of estrogen receptor beta. Thus, the inflammatory-immune system appears to be also a major target of estrogens. However, the effects of estrogens on the immuno-inflammatory system appear ambiguous, as in some models, estradiol rather promotes inflammation (by increasing interferon gamma which could elicit plaque destabilization). A better understanding of the mechanisms of estrogens on the normal and atheromatous arteries is required and should help to optimize the prevention of cardiovascular disease after menopause.
引用
收藏
页码:1226 / 1232
页数:7
相关论文
共 28 条
  • [1] Brouchet L, 2001, CIRCULATION, V103, P423
  • [2] F9 embryonal carcinoma cells engineered for tamoxifen-dependent Cre-mediated site-directed mutagenesis and doxycycline-inducible gene expression
    Chiba, H
    Chambon, P
    Metzger, D
    [J]. EXPERIMENTAL CELL RESEARCH, 2000, 260 (02) : 334 - 339
  • [3] ANALYSIS OF TRANSCRIPTION AND ESTROGEN INSENSITIVITY IN THE FEMALE MOUSE AFTER TARGETED DISRUPTION OF THE ESTROGEN-RECEPTOR GENE
    COUSE, JF
    CURTIS, SW
    WASHBURN, TF
    LINDZEY, J
    GOLDING, TS
    LUBAHN, DB
    SMITHIES, O
    KORACH, KS
    [J]. MOLECULAR ENDOCRINOLOGY, 1995, 9 (11) : 1441 - 1454
  • [4] Estrogen receptor null mice: What have we learned and where will they lead us?
    Couse, JF
    Korach, KS
    [J]. ENDOCRINE REVIEWS, 1999, 20 (03) : 358 - 417
  • [5] T and B lymphocytes play a minor sole in atherosclerotic plaque formation in the apolipoprotein E-deficient mouse
    Dansky, HM
    Charlton, SA
    Harper, MM
    Smith, JD
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (09) : 4642 - 4646
  • [6] Estradiol alters nitric oxide production in the mouse aorta through the α-, but not β-, estrogen receptor
    Darblade, B
    Pendaries, C
    Krust, A
    Dupont, S
    Fouque, MJ
    Rami, J
    Chambon, P
    Bayard, F
    Arnal, JF
    [J]. CIRCULATION RESEARCH, 2002, 90 (04) : 413 - 419
  • [7] Dupont S, 2000, DEVELOPMENT, V127, P4277
  • [8] Prevention of fatty streak formation of 17 beta-estradiol is not mediated by the production of nitric oxide in apolipoprotein E-deficient mice
    Elhage, R
    Bayard, F
    Richard, V
    Holvoet, P
    Duverger, N
    Fievet, C
    Arnal, JF
    [J]. CIRCULATION, 1997, 96 (09) : 3048 - 3052
  • [9] 17 beta-estradiol prevents fatty streak formation in apolipoprotein E-deficient mice
    Elhage, R
    Arnal, JF
    Pieraggi, MT
    Duverger, N
    Fievet, C
    Faye, JC
    Bayard, F
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (11) : 2679 - 2684
  • [10] Loss of atheroprotective effect of estradiol in immunodeficient mice.
    Elhage, R
    Clamens, S
    Reardon-Alulis, C
    Getz, GS
    Fievet, C
    Maret, A
    Arnal, JF
    Bayard, F
    [J]. ENDOCRINOLOGY, 2000, 141 (01) : 462 - 465